Leveraging their experience as the primary lender in the pharmacy sector, Woodsford TradeBridge have created a new product specifically tailored to the needs of dental practices. Combining technology and expertise with a complete understanding of NHS practice, the new product can release up to three times the value of a practice’s NHS revenue.
Through analysis of a practice’s trading history, supported by six months of its NHS payment statements, three months of bank statements and two years’ worth of annual accounts, Woodsford TradeBridge calculates an individual credit limit.
With a simple application process, where you deal directly with the decision maker, the new finance facility can be up and running within days.
Seb Miles, Managing Director of RxBridge, said:
“Through the Coronavirus pandemic we have seen how valuable the availability of working capital has been to meet the additional operating cost of staying safe, open and stocked – its enabled pharmacies to increase their support within the community. This encouraged us to accelerate our plans to release the dental product. As the dental sector begins to come out of lockdown, having access to additional working capital will enable practices to respond to the extraordinary needs of the current time or even to grasp opportunities for growth.”
To read the full press release click here.